Home » Newsletters » BioWorld Science

BioWorld Science

March 21, 2017

View Archived Issues

Threshold Pharmaceuticals and Molecular Templates agree to merge

NightstaRx initiates phase I/II study of gene therapy to treat X-linked retinitis pigmentosa

EURE-CART project holds launch meeting

Opiant initiates phase II trial of OPNT-001 for bulimia nervosa

BioLineRx reports partial results from phase II trial of BL-8040 for mobilization of stem cells

Actelion Pharmaceuticals presents novel antibacterial compounds

Lupin discovers new sodium channel protein type 9 subunit alpha blockers

OncoArendi Therapeutics patents chitinase and chitotriosidase-1 inhibitors

FORMA Therapeutics synthesizes new histone deacetylase 8 inhibitors

Nimbus Lakshmi presents novel TYK2 inhibitors

Tyrosine-protein kinase Mer inhibitors discovered at Dong-A Socio Holdings

Phase III MONARCH 2 breast cancer study of abemaciclib meets primary endpoint

Jazz announces promising phase III results for JZP-110 in obstructive sleep apnea

Mallinckrodt closes sale of intrathecal therapy business to Piramal Critical Care

argenx collaborates with Broteio to develop therapeutic antibody for severe autoimmune diseases

Aevi reports topline results from SAGA trial of AEVI-001 in ADHD

Bristol-Myers Squibb and CytomX expand Probody discovery collaboration

FDA sets action date to complete NDA review for latanoprostene bunod

Global Genomics announces knowPLAQUE diagnostic blood test for plaque in coronary arteries

Loxo and Ventana Medical Systems collaborate on companion diagnostic for LOXO-101

First-in-human data presented for tenofovir disoproxil orotate

Full results reported for ORION-1 trial of inclisiran in patients at cardiovascular risk

Ra Pharmaceuticals initiates phase II study of RA-101495 for PNH

Ono Pharmaceutical and X-Chem form oncology discovery collaboration

Phase II data presented for buparlisib in patients with metastatic head and neck carcinoma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...